GlassScriptPhysician profile
Ashley M Liese
NPI 1427546894
$10,072.78
in general payments reported to CMS, 2019-2025
44 companies · $1,593 in 2025
The $1,593 reported for 2025 was more than what 93% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $2,166 · 2022: $1,894 · 2023: $2,471 · 2024: $1,948 · 2025: $1,593.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,006 · Education: $6.71.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,005.77 |
| Education | $6.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $1,375.30 | 2021-2025 | |
| Abbvie INC. | $1,209.92 | 2021-2025 | |
| Novo Nordisk INC | $1,075.59 | 2021-2025 | Ozempic, Rybelsus, Wegovy |
| Astrazeneca Pharmaceuticals LP | $901.14 | 2021-2025 | Farxiga, Airsupra, Breztri |
| Lilly USA, LLC | $895.02 | 2021-2025 | Jardiance, Mounjaro, Zepbound |
| Boehringer Ingelheim Pharmaceuticals, INC. | $426.83 | 2021-2025 | Jardiance, Tradjenta, Spiriva Respimat |
| Vanda Pharmaceuticals INC. | $326.91 | 2021-2023 | Hetlioz |
| Glaxosmithkline, LLC. | $321.75 | 2021-2025 | Trelegy Ellipta, Shingrix, Arexvy |
| Exact Sciences Corporation | $319.55 | 2023-2025 | Cologuard Collection Kit |
| Nestle Healthcare Nutrition INC. | $255.81 | 2022-2023 | |
| Biohaven Pharmaceuticals, INC. | $251.34 | 2021 | |
| Novartis Pharmaceuticals Corporation | $229.69 | 2021-2023 | |
| Takeda Pharmaceuticals U.S.A., INC. | $228.32 | 2021-2023 | Trintellix |
| Antares Pharma, INC. | $196.51 | 2021-2025 | Xyosted, Tlando, Nocdurna |
| Amgen INC. | $191.72 | 2022-2025 | Repatha, Otezla, Evenity |
Show all 44 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ashley Liese listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.